There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3 rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7 th to 9 th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy

Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kääb S, et al. (2011). Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. THROMBOSIS AND HAEMOSTASIS, 106, 1012-1019 [10.1160/TH11-07-0517].

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

BORIANI, GIUSEPPE;
2011

Abstract

There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3 rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7 th to 9 th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy
2011
Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kääb S, et al. (2011). Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. THROMBOSIS AND HAEMOSTASIS, 106, 1012-1019 [10.1160/TH11-07-0517].
Kirchhof P; Lip GY; Van Gelder IC; Bax J; Hylek E; Kääb S; Schotten U; Wegscheider K; Boriani G; Ezekowitz M; Diener H; Heidbuchel H; Lane D; Mont L; Willems S; Dorian P; Vardas P; Breithardt G; Camm AJ.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/119144
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 81
  • ???jsp.display-item.citation.isi??? 75
social impact